US$ 29.71
glp-1 japan Real-world use of glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes: A retrospective database study (DEFINE-G) Japan GLP-1 Agonists Weight Loss
Description
Among those initiating GLP1 receptor agonists, 57.5% started with liraglutide, 42.0% with semaglutide, and 0.5% with dulaglutide

[DOI] [PubMed] [Google Scholar] 23.Lpez de Maturana R, Donnelly D

While GLP-1RA has proven clinical efficacy, the need for more comprehensive studies, to ensure their long-term safety, is essential to optimize their therapeutic role and improve patient outcomes on a global scale

Insurance companies often evaluate whether treatment is medically necessary
Recent clinical trial data also adds support to this view

doi: 10.1016/j.cmet.2018.04.008
